<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1595720</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2025.1595720</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>A novel loss-of-function <italic>SYCP2</italic> variant causes asthenoteratozoospermia in infertile males</article-title>
<alt-title alt-title-type="left-running-head">Liu et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgene.2025.1595720">10.3389/fgene.2025.1595720</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Liu</surname>
<given-names>Cong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2943496/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhang</surname>
<given-names>Yinfeng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Youming</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Luo</surname>
<given-names>Haining</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2260271/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Center for Reproductive Medicine</institution>, <institution>Tianjin Central Hospital of Gynaecology Obsterics</institution>, <addr-line>Tianjin</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Tianjin Institute of Gynaecology Obsteric</institution>, <institution>Tianjin Central Hospital of Gynaecology Obsterics</institution>, <addr-line>Tianjin</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Tianjin Key Laboratory of Human Development and Reproductive Regulation</institution>, <institution>Tianjin Central Hospital of Gynaecology Obsterics</institution>, <addr-line>Tianjin</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/91434/overview">Musharraf Jelani</ext-link>, Islamia College Peshawar, Pakistan</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1408711/overview">Shenfei Sun</ext-link>, Fudan University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2298711/overview">Zhi Cheng</ext-link>, Chongqing Medical University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Haining Luo, <email>30317012@nankai.edu.cn</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>05</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1595720</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>03</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>04</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Liu, Zhang, Zhao and Luo.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Liu, Zhang, Zhao and Luo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background:</title>
<p>Infertility is a multiplex disorder in the reproductive system. Unexplained infertility affects 2%-3% of reproductive-aged couples. Male factors contribute to about half of all infertility cases. About 15% of these cases are predicted to have a genetic etiology. With the wide application of whole exome sequencing (WES), more and more variations in male infertility have been identified.</p>
</sec>
<sec>
<title>Methods:</title>
<p>A patient diagnosed with asthenoteratozoospermia was involved in this study. WES was performed in the patient, and Sanger sequencing was used to confirm the variation. Mini-gene splicing assays were performed to validate the effect on the alternative splicing of the variation.</p>
</sec>
<sec>
<title>Results:</title>
<p>A novel heterozygous splice variant was identified in SYCP2 (c.2600&#x2b; 5G&#x3e;C) in the patient ,which inherited from his phenotypically normal mother. SYCP2 encodes a protein critical for the synapsis of homologous chromosomes during meiosis I, and its disruption can impair spermatogenesis. Mini-gene splicing assays confirmed that this splicing variant impacted alternative splicing and that the stop codon appeared early, which was very likely to result in the loss of function of the protein and lead to the occurrence of male infertility.</p>
</sec>
<sec>
<title>Conclusion:</title>
<p>Our results suggested that the c.2600&#x2b;5G&#x3e;C variation in SYCP2 might be the genetic etiology for male infertility in this pedigree. This finding expanded the known genotype spectrum of male infertility and provided new etiological information for male infertility.</p>
</sec>
</abstract>
<kwd-group>
<kwd>male infertility</kwd>
<kwd>whole exome sequence</kwd>
<kwd>
<italic>SYCP2</italic>
</kwd>
<kwd>gene variation</kwd>
<kwd>mini-gene splicing assay</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Genetics of Common and Rare Diseases</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Infertility is an important health problem with a multifactorial etiology that affects approximately 15% of couples who attempt pregnancy globally (<xref ref-type="bibr" rid="B15">Tamrakar and Bastakoti, 2019</xref>). In approximately 50% of these couples, a male factor plays an important role, which may exist either alone or in combination with female factors (<xref ref-type="bibr" rid="B19">Xie et al., 2018</xref>). Male infertility is a multifactorial pathological condition affecting approximately 7% of the male population (<xref ref-type="bibr" rid="B7">Li et al., 2024</xref>). The genetic factor of male infertility is highly complex, as testis and semen histological phenotypes are extremely heterogeneous, and at least 2000 genes are involved in spermatogenesis (<xref ref-type="bibr" rid="B6">Krausz and Riera-Escamilla, 2018</xref>). Understanding the genetic etiology of male infertility can provide genetic counselling and subsequent therapeutic interventions to patients, such as intracytoplasmic sperm injection (ICSI) and <italic>in vitro</italic> fertilization (IVF), as well as seeking donor sperm or adoption (<xref ref-type="bibr" rid="B7">Li et al., 2024</xref>). Therefore, identifying genetic variants associated with male infertility can provide patients with meaningful and actionable information.</p>
<p>The identification of novel candidate genes in infertile males has increased rapidly since the implementation of next-generation sequencing, including whole genome sequencing (WGS) and whole exome sequencing (WES). The molecular diagnostic project has become an important mean of clinical diagnosis. However, many genes have not yet accumulated sufficient evidence to be confidently implicated in male infertility.</p>
<p>
<italic>Synaptonemal complex protein 2 (SYCP2)</italic> is a novel candidate gene associated with autosomal dominant male infertility and is located at 20q13.33 (<xref ref-type="bibr" rid="B12">Schilit et al., 2020</xref>). <italic>SYCP2</italic> encodes synaptonemal complex protein 2, an axial element in the proteinaceous synaptonemal complex (SC) (<xref ref-type="bibr" rid="B10">Schalk et al., 1999</xref>). SC assembly contributes to the pairing and segregation of homologous chromosomes during meiosis (<xref ref-type="bibr" rid="B8">Page and Hawley, 2003</xref>). <italic>SYCP2</italic> is important for spermatogenesis (<xref ref-type="bibr" rid="B14">Takemoto et al., 2020</xref>).</p>
<p>This study investigated the genetic cause of male infertility in a Chinese patient. WES and subsequent Sanger sequencing revealed a novel heterozygous variant in <italic>SYCP2</italic> (c.2600 &#x2b; 5G&#x3e;C). This variation was inherited from the patient&#x2019;s healthy mother. The variation was verified to impact the alternative splicing of <italic>SYCP2</italic> and introduced an early stop codon that resulted in the prematuration and loss of function of <italic>SYCP2</italic>.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Patients</title>
<p>A family with a proband diagnosed with male infertility was involved in this study. The family members who participated in this study were thoroughly informed about this study. This study was approved by the medical ethics committee of Tianjin Central Hospital of Gynecology Obstetrics (No. ZY2023001).</p>
</sec>
<sec id="s2-2">
<title>2.2 WES, variant interpretation, and sanger sequencing</title>
<p>Genomic DNA (gDNA) was isolated from peripheral blood via the DNeasy Blood and Tissue Kit (QIAGEN, Germany). WES was performed via the sequencing platform of the Beijing Genomics Institute (BGI). All steps were performed according to the manufacturer&#x2019;s instructions. Exomes were hybridized and captured by the xGen Exome Research Panel of Integrated DNA Technologies (IDT, America) and sequenced on the MGI-2000. The average sequencing depth was 100x&#x2012;150x, and the data quality was Q20 &#x2265; 90% and Q30 &#x2265; 90%. The original data obtained by sequencing were filtered through fastp software (<xref ref-type="bibr" rid="B2">Chen et al., 2018</xref>) and then passed through BWA software (<xref ref-type="bibr" rid="B5">Houtgast et al., 2018</xref>). The sequenced reads were collected, filtered for quality, and aligned to the human reference genome (hg19/GRCh37). The sequenced variants were annotated via ANNOVAR software (<xref ref-type="bibr" rid="B16">Wang et al., 2010</xref>)<sup>,</sup> and mutations were screened on the basis of patients&#x2019; clinical information, population databases, disease databases, and bioinformatic prediction tools. Candidate pathogenic variants were scored in accordance with the criteria set by the American College of Medical Genetics and Genomics (ACMG) (<xref ref-type="bibr" rid="B9">Richards et al., 2015</xref>) and confirmed by Sanger sequencing.</p>
</sec>
<sec id="s2-3">
<title>2.3 Mini-gene construction</title>
<p>To construct the mini gene, we amplified the <italic>SYCP2</italic> fragment from the sectional intron26 (627&#xa0;bp) to the sectional intron27 (84&#xa0;bp) via nested polymerase chain reaction (PCR) with a primer pair and added the endonuclease recognition sequences of KpnI and XhoI to the front and end of the fragment, respectively. The detailed methods were presented in the supplementary materials. The PCR products were purified via alcohol and digested along with the vector pcMINI via the endonucleases KpnI and XhoI (New England Biolabs, America). The digested PCR products and vectors were purified via electrophoresis and ligated together with T4 ligase (New England Biolabs, America). Ligase products were transformed into DH5&#x3b1; competent cells, which were subsequently plated on LB plates coated with ampicillin. Single clones were then selected for proliferation and Sanger sequencing. The identified colonies were amplified, and plasmid DNA without endotoxin was extracted via the Rapid Plasmid Mini Kit (Simgen, China). The primers used in this study are listed in the <xref ref-type="sec" rid="s13">Supplementary Material</xref>.</p>
</sec>
<sec id="s2-4">
<title>2.4 Cell transfection</title>
<p>Human embryonic kidney 293T (HEK293T) cells and HeLa cells were cultured in DMEM/high glucose (Gibco, America) supplemented with 10% FBS (Sigma, America) in a 37&#xb0;C constant-temperature water bath incubator at 5% CO<sub>2</sub>. The cells were dissociated into single cells using trypsin-EDTA (Thermo Fisher, America) after they reached 80% confluence. The cells were counted, and 4 &#xd7; 10<sup>5</sup> cells were seeded in 6-well plates 24&#xa0;h before transfection. The cell medium was changed to Opti-MEM (Thermo Fisher, America) 2&#xa0;h before transfection. Lipofectamine 2000 (Thermo Fisher, America) was incubated for 20&#xa0;min at room temperature, the mixture was mixed thoroughly with 1&#xa0;&#x3bc;g of plasmid, and then, the mixture was gently added to the cell medium. The cell medium was replaced with fresh culture medium supplemented with 10% FBS 12&#xa0;h after transfection.</p>
</sec>
<sec id="s2-5">
<title>2.5 RT-PCR and sanger sequencing</title>
<p>Total RNA was extracted 48&#xa0;h after transfection via TRIzol reagent (TaKaRa, China) following routine procedures. Reverse transcription&#x2012;polymerase chain reaction (RT-PCR) was performed via ABScript III RT Master Mix for qPCR with gDNA Remover (ABclonal, China) according to the manufacturer&#x2019;s instructions. cDNA was used as a template for PCR with the primer pair F/R (Supplementary Material). The amplification products were subjected to electrophoresis on a 1% agarose gel and Sanger sequencing.</p>
</sec>
<sec id="s2-6">
<title>2.6 Bioinformatics analyses</title>
<p>The <italic>SYCP2</italic> gene sequence was obtained from the NCBI Gene database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gene/">https://www.ncbi.nlm.nih.gov/gene/</ext-link>). The molecular structure of the cryo-EM structure of GATOR1 was viewed with Mol&#x2a; View (<xref ref-type="bibr" rid="B13">Sehnal et al., 2021</xref>) and stored in the RCSB PDB (<xref ref-type="bibr" rid="B1">Berman et al., 2000</xref>).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Clinical report for the patient</title>
<p>We sought to identify the genetic etiology of infertility for a male research participant who presented with a 2-year history of infertility at age 30. His assessment indicated asthenoteratozoospermia (AT) (the semen test results were shown in <xref ref-type="table" rid="T1">Table 1</xref>) in accordance with the WHO Laboratory Manual for the Examination and Handling of Human Semen, fifth edition. The patient displayed no dysmorphic features and had normal serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and testosterone. Y chromosome microdeletions were normal. The couple pursued ICSI as a treatment for male infertility. However, the couple did not become pregnant after ICSI treatment at the center. Despite multiple attempts at ICSI and despite successful fertilization, the couple was unable to obtain viable embryos. Eventually, the patient discontinued the treatment.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Patient semen characteristics.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Semen parameters</th>
<th align="left">The patient in this study</th>
<th align="left">Reference values</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Total semen volume (mL)</td>
<td align="center">1</td>
<td align="center">&#x3e;1.5</td>
</tr>
<tr>
<td align="left">Concentration (10<sup>6</sup>/mL)</td>
<td align="center">28</td>
<td align="center">&#x3e;15.0</td>
</tr>
<tr>
<td align="left">the normal morphology rate</td>
<td align="center">3</td>
<td align="center">&#x3e;4</td>
</tr>
<tr>
<td align="left">Motility (%)</td>
<td align="center">23</td>
<td align="center">&#x3e;40.0</td>
</tr>
<tr>
<td align="left">Progressive motility (%)</td>
<td align="center">13</td>
<td align="center">&#x3e;32.0</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-2">
<title>3.2 Genetic analysis identifies novel heterozygous <italic>SYCP2</italic> variants in the patient</title>
<p>To explore the genetic factors contributing to the infertility of the patient, WES and subsequent validation through Sanger sequencing were performed. The patient was found to have a heterozygous variant in intron 27 of <italic>SYCP2</italic>, NM_014258.4:c.2600 &#x2b; 5G&#x3e;C (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Sanger sequencing via the primer SYCP2-F/R confirmed that this variant was inherited from the patient&#x2019;s mother, who had a normal phenotype (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Identification of a heterozygous variation in <italic>SYCP2</italic>. <bold>(A)</bold> Pedigree of the family. The proband (II-1) was diagnosed with male infertility, as indicated by filled symbols with arrows in the pedigree. <bold>(B)</bold> Sanger sequencing of the proband and his parents revealed a c.2600 &#x2b; 5G&#x3e;C mutation in the <italic>SYCP2</italic> gene, which was maternally inherited.</p>
</caption>
<graphic xlink:href="fgene-16-1595720-g001.tif"/>
</fig>
<p>Notably, this variant was absent in several major population databases, including the 1KGP (1000 Genomes Project, Phase 3), ESP6500 (Genome Aggregation Database, V2), gnomAD (Genome Aggregation Database, r2.0.1) and ExAC (Exome Aggregation Consortium, r0.3.1) databases, highlighting its rarity within these populations. This is the first report of this phenomenon in this study. Bioinformatics analysis via &#x201c;Ada&#x201d; and &#x201c;RF&#x201d; scores predicted that this variant was likely to influence splicing (<xref ref-type="sec" rid="s13">Supplementary Table S2</xref>). According to the ACMG guidelines, the novel variation c.2600 &#x2b; 5G&#x3e;C was designated as a variant of uncertain significance (VUS).</p>
</sec>
<sec id="s3-3">
<title>3.3 Functional splicing examination of the variant with mini-gene splicing assays</title>
<p>To validate the effect of the c.2600 &#x2b; 5G&#x3e;C variation on RNA alternative splicing, we conducted a mine gene splicing assay by constructing containing the wild-type (wt) and mutation-type (mut) target DNA fragments (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The vectors were confirmed by Sanger sequencing (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Plasmid DNA without endotoxin was transfected into HEK293T cells and HeLa cells. The total RNA of the transfected cells was extracted, and reverse transcription was performed to obtain cDNA. Agarose electrophoresis of the RT-PCR products revealed two distinct splicing patterns (<xref ref-type="fig" rid="F2">Figures 2C,D</xref>). The full uncropped Gels image presented in <xref ref-type="sec" rid="s13">Supplementary Figure S2</xref>. Sanger sequencing revealed that abnormal splicing occurred in cells transfected with the mutation plasmid and that the mutation C.2600 &#x2b; 5G&#x3e;C affected the normal splicing of gene mRNA (<xref ref-type="fig" rid="F2">Figure 2E</xref>). The detection results of pcMINI and PCMINI-C were consistent, as shown in<xref ref-type="sec" rid="s13">Supplementary Figure S1</xref>. There was one abnormal transcript after mutation: exon 27 skipping. The mutation caused exon 27 skipping, which was expressed in the cDNA as c.2530_2600del. Exon 27 skipping caused a subsequent frameshift and produced an early stop codon in exon 28, which might produce a truncated protein 844 aa in length. Thus, the variation was described as SYCP2:c.2600 &#x2b; 5G&#x3e;C (p.Lys845&#x2a;).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Examination of functional splicing of the variant with mini-gene splicing assays. <bold>(A)</bold> Schematic diagram of the constructed mini-gene. ExA and ExB are exonic sequences of the plasmid. <bold>(B)</bold> Sanger sequencing confirmed that the wild-type and mutant fragments were successfully introduced into the mini-gene construct. <bold>(C)</bold> RT-PCR was performed to verify alternative splicing in the wild-type and mutant groups. Abnormal splicing bands in the mutant groups were not detected in the HEK293T cells or the HeLa cells. Agarose gel electrophoresis revealed that the wt had only one band, and the labelled a and mut proteins produced two bands, labelled a and b. <bold>(D)</bold> The bands in a and b were identified via Sanger sequencing. Alternative splicing was affected by the c.2600 &#x2b; 5G&#x3e;C variation in SYCP2. PCR product sequencing revealed exon 27 skipping. <bold>(E)</bold> Alternative schematic diagram. wt, wild type; mut, mutant type; M, DL2000 DNA ladder.</p>
</caption>
<graphic xlink:href="fgene-16-1595720-g002.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Translation analysis and protein modelling</title>
<p>We further analysed the cDNA sequence of <italic>SYCP2</italic> and found that the variation led to a frameshift and early appearance of the stop codon, which resulted in the prematuration of SYCP2 with 844 amino acid residues. Mutation of SYCP2 resulted in the loss of the whole coiled-coil (CC) domain (<xref ref-type="fig" rid="F3">Figure 3</xref>). In rodents, SYCP2 directly interacts with SYCP1 and SYCP3 through its C-terminal domain and internal curly helix domain, respectively (<xref ref-type="bibr" rid="B18">Winkel et al., 2009</xref>). The deletion of the SYCP3-interacting domain of SYCP2 leads to severe defects in SC formation in mice, and males are sterile (<xref ref-type="bibr" rid="B21">Yang et al., 2006</xref>). The deletion of the CC domain meant that the protein was fundamentally changed and that its function was severely impaired.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Schematic of the <italic>SYCP2</italic> gene and protein domain. <bold>(A)</bold> gDNA structure of <italic>SYCP2</italic>. The red asterisk represents the variation site. <bold>(B)</bold> cDNA structure of SYCP2. <bold>(C)</bold> Schematic diagram of the SYCP2 domain. The SYCP2 protein contains the ARLD domain, SLD domain and CC domain. <bold>(D)</bold> Schematic diagram of the HORMA and SYCP3 structures. The connected parts interact with the SYCP2 domain. <bold>(E)</bold> Schematic diagram of the predicted protein structure of mutated SYCP2.</p>
</caption>
<graphic xlink:href="fgene-16-1595720-g003.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>Many Mendelian disorders are genetically heterogeneous, with a multitude of different disease genes in which a variety of disease-causing variants have been discovered (<xref ref-type="bibr" rid="B22">Zhao et al., 2015</xref>). With the development of next-generation sequencing (NGS), an increasing number of disease-causing genes have been discovered. Accurate molecular diagnosis can provide an important basis for genetic counselling, specific treatment and family planning, and prognosis management (<xref ref-type="bibr" rid="B4">Ellingford et al., 2015</xref>).</p>
<p>Male infertility is a common disorder among reproductive-aged couples. Understanding the precise causes may directly inform therapies for infertile couples (<xref ref-type="bibr" rid="B11">Schilit, 2019</xref>). In this study, we described a patient with a clinical presentation compatible with male infertility and discovered a novel germline splicing variant, c.2600 &#x2b; 5G&#x3e;C, in <italic>SYCP2</italic>. Our experimental results revealed that this mutation caused exon 27 skipping, leading to subsequent changes in the reading frame. A premature termination codon (PTC) was generated within exon 28, and a truncated protein with a length of 844 aa was likely to be generated, destroying the curly helix region, which could form a heterodimer with the SYCP3 protein and play an important role in the assembly of the synaptic complex and the chromosome coupling process (<xref ref-type="bibr" rid="B14">Takemoto et al., 2020</xref>). Mice lacking the coiled-coil domain of <italic>Sycp2</italic> exhibit spermatocyte apoptosis and male-specific infertility (<xref ref-type="bibr" rid="B21">Yang et al., 2006</xref>). According to ACMG guidelines, the c.2600 &#x2b; 5G&#x3e;C variant was predicted to be likely pathogenic (LP), which was upgraded from VUS. The detection of the new mutation expanded the variation spectrum of <italic>SYCP2</italic> and provided the basis for the subsequent treatment of this family. However, surprisingly, the concentration of the patient&#x2019;s semen was normal. We suspected that meiotic errors such as aneuploidy or DNA fragmentation due to SYCP2 dysfunction could lead to failed fertilization, even if sperm were present in this patient.</p>
<p>The penetrance of the disorder may be unknown due to the ascertainment of affected cases (<xref ref-type="bibr" rid="B7">Li et al., 2024</xref>). Indeed, there was an azoospermic proband with a homozygous loss-of-function variant in <italic>SYCP2</italic> whose father might have incomplete penetrance in the heterozygous state (<xref ref-type="bibr" rid="B20">Xu et al., 2023</xref>). Notably, in this study we found that female carrier was fertile, and maternally inherited SYCP2 variants had been seen in other reports (<xref ref-type="bibr" rid="B7">Li et al., 2024</xref>). In addition, disruption of Sycp2 gene has been shown to cause male infertility, but only female infertility in mouse model (<xref ref-type="bibr" rid="B21">Yang et al., 2006</xref>), suggesting that the relationship between SYCP2 and male infertility does not extend to female infertility. It was speculated that SYCP2 homologue SYCP2L may play an important role in female fertility (<xref ref-type="bibr" rid="B7">Li et al., 2024</xref>).</p>
<p>Mammalian RNA splicing is a delicate process whose precise coordination is not fully understood, but its regulation is critical for the proper expression of most genes and their isoforms (<xref ref-type="bibr" rid="B3">Zheng, 2004</xref>). Accurate pre-mRNA splicing is critical for proper protein translation and relies on the existence of consistent cis sequences that define exon&#x2012;intron boundaries and regulatory sequences recognized by splicing mechanisms (<xref ref-type="bibr" rid="B17">Wang et al., 2024</xref>). Variants that disrupt normal pre-mRNA splicing are increasingly recognized as major causes of monogenic disorders. Mutations in the canonical splice sequences usually lead to single-exon skipping, but the exact effect of specific splicing mutations on alternative pre-mRNA splicing needs further validation. Some nonclassical splicing events do not result in frameshifts, which might have a mild effect on protein function. In our study, the c.2600 &#x2b; 5G&#x3e;C variant in <italic>SYCP2</italic> causes the skipping of exon 27, as expected, and results in a frameshift and early appearance of a stop codon, causing the <italic>SYCP2</italic> protein to be prematurated and lose its normal function. The importance of understanding this process and being able to predict which variants alter splicing is therefore essential to understanding human disease.</p>
<p>
<italic>SYCP2</italic> (OMIM 604105) is located on chromosome 20q13.33 and spans 70&#xa0;kb in length. The <italic>SYCP2</italic> protein contains 1,530 amino acids. SYCP2 is a component of the synaptic complex and plays an important role in meiosis. At present, relatively few cases of <italic>SYCP2</italic> gene mutations have been reported, with the majority being loss-of-function mutations. In a recent study, three frameshift variants in <italic>SYCP2</italic> were identified in men with azoospermia, suggesting that heterozygous loss-of-function variants in <italic>SYCP2</italic> might be responsible for the low sperm count and subsequent infertility (<xref ref-type="bibr" rid="B12">Schilit et al., 2020</xref>). Substantial experimental evidence supports the role of <italic>SYCP2</italic> in male infertility, reinforcing the strong clinical validity of the classification of <italic>SYCP2</italic> as a gene associated with autosomal dominant male infertility (<xref ref-type="bibr" rid="B7">Li et al., 2024</xref>).</p>
<p>Nevertheless, there were also several limitations to this study. The results of the mini-gene splicing assay were not further validated in patient samples and we did not confirm the presence of the truncated protein in the variant by western blot. Moreover, histological analysis of the patient&#x2019;s testicles was not performed.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>5 Conclusion</title>
<p>In conclusion, in this article, we describe a proband with male infertility harboring a novel splicing variation, c.2600 &#x2b; 5G&#x3e;C (p.Lys845&#x2a;), in <italic>SYCP2</italic> gene. The effect of this variation on alternative splicing and translation was confirmed by mini-gene splice assays. Our study provided a new source of evidence for the pathogenicity of splicing variation and expanded the phenotype and genotype spectrum of male infertility.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s13">Supplementary Material</xref>. The detailed original data is uploaded to figshare, DOI:<ext-link ext-link-type="uri" xlink:href="https://10.6084/m9.figshare.28925081">10.6084/m9.figshare.28925081</ext-link>.</p>
</sec>
<sec sec-type="ethics-statement" id="s7">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>LC: Conceptualization, Data curation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review and editing. ZnY: Conceptualization, Data curation, Methodology, Writing &#x2013; review and editing. ZoY: Writing &#x2013; review and editing. LH: Funding acquisition, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Jinmen medical staff of Tianjin.</p>
</sec>
<ack>
<p>The authors would like to express their sincere gratitude to the patients involved in this study.</p>
</ack>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s11">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s12">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s13">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2025.1595720/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2025.1595720/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Supplementaryfile1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berman</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Westbrook</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gilliland</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>T. N.</given-names>
</name>
<name>
<surname>Weissig</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>The protein data bank</article-title>. <source>Nucleic Acids Res.</source> <volume>28</volume> (<issue>1</issue>), <fpage>235</fpage>&#x2013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>fastp: an ultra-fast all-in-one FASTQ preprocessor</article-title>. <source>Bioinformatics</source> <volume>34</volume> (<issue>17</issue>), <fpage>i884</fpage>&#x2013;<lpage>i890</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bty560</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellingford</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Sergouniotis</surname>
<given-names>P. I.</given-names>
</name>
<name>
<surname>Lennon</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bhaskar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>S. G.</given-names>
</name>
<name>
<surname>Hillman</surname>
<given-names>K. A.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Pinpointing clinical diagnosis through whole exome sequencing to direct patient care: a case of Senior-Loken syndrome</article-title>. <source>Lancet</source> <volume>385</volume> (<issue>9980</issue>), <fpage>1916</fpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(15)60496-2</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houtgast</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Sima</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Bertels</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Al-Ars</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Hardware acceleration of BWA-MEM genomic short read mapping for longer read lengths</article-title>. <source>Comput. Biol. Chem.</source> <volume>75</volume>, <fpage>54</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.compbiolchem.2018.03.024</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krausz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Riera-Escamilla</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Genetics of male infertility</article-title>. <source>Nat. Rev. Urol.</source> <volume>15</volume> (<issue>6</issue>), <fpage>369</fpage>&#x2013;<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1038/s41585-018-0003-3</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schilit</surname>
<given-names>S. L. P.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Novel loss-of-function SYCP2 variants in infertile males upgrade the gene-disease clinical validity classification for SYCP2 and male infertility to strong</article-title>. <source>Genes (Basel)</source> <volume>15</volume> (<issue>8</issue>), <fpage>1092</fpage>. <pub-id pub-id-type="doi">10.3390/genes15081092</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Page</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Hawley</surname>
<given-names>R. S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Chromosome choreography: the meiotic ballet</article-title>. <source>Science</source> <volume>301</volume> (<issue>5634</issue>), <fpage>785</fpage>&#x2013;<lpage>789</lpage>. <pub-id pub-id-type="doi">10.1126/science.1086605</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richards</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aziz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bale</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bick</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gastier-Foster</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the association for molecular pathology</article-title>. <source>Genet. Med.</source> <volume>17</volume> (<issue>5</issue>), <fpage>405</fpage>&#x2013;<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schalk</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Offenberg</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Groot</surname>
<given-names>N. P.</given-names>
</name>
<name>
<surname>Hoovers</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Heyting</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Isolation and characterization of the human SCP2 cDNA and chromosomal localization of the gene</article-title>. <source>Mamm. Genome</source> <volume>10</volume> (<issue>6</issue>), <fpage>642</fpage>&#x2013;<lpage>644</lpage>. <pub-id pub-id-type="doi">10.1007/s003359901062</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schilit</surname>
<given-names>S. L. P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Recent advances and future opportunities to diagnose male infertility</article-title>. <source>Curr. Sex. Health Rep.</source> <volume>11</volume> (<issue>4</issue>), <fpage>331</fpage>&#x2013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1007/s11930-019-00225-8</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schilit</surname>
<given-names>S. L. P.</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Friedrich</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kammin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wilch</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hanscom</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>SYCP2 translocation-mediated dysregulation and frameshift variants cause human male infertility</article-title>. <source>Am. J. Hum. Genet.</source> <volume>106</volume> (<issue>1</issue>), <fpage>41</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2019.11.013</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sehnal</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bittrich</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Deshpande</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Svobodov&#xe1;</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Berka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bazgier</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mol&#x2a; Viewer: modern web app for 3D visualization and analysis of large biomolecular structures</article-title>. <source>Nucleic Acids Res.</source> <volume>49</volume> (<issue>W1</issue>), <fpage>W431</fpage>&#x2013;<lpage>W437</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab314</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takemoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Imai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kawasaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Carlton</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Ishiguro</surname>
<given-names>K. I.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Sycp2 is essential for synaptonemal complex assembly, early meiotic recombination and homologous pairing in zebrafish spermatocytes</article-title>. <source>PLoS Genet.</source> <volume>16</volume> (<issue>2</issue>), <fpage>e1008640</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1008640</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamrakar</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Bastakoti</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Determinants of infertility in couples</article-title>. <source>J. Nepal Health Res. Counc.</source> <volume>17</volume> (<issue>1</issue>), <fpage>85</fpage>&#x2013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.33314/jnhrc.1827</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>. <source>Nucleic Acids Res.</source> <volume>38</volume> (<issue>16</issue>), <fpage>e164</fpage>. <pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>A novel variation in DEPDC5 causing familial focal epilepsy with variable foci</article-title>. <source>Front. Genet.</source> <volume>15</volume>, <fpage>1414259</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2024.1414259</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winkel</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Alsheimer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ollinger</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Benavente</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Protein SYCP2 provides a link between transverse filaments and lateral elements of mammalian synaptonemal complexes</article-title>. <source>Chromosoma</source> <volume>118</volume> (<issue>2</issue>), <fpage>259</fpage>&#x2013;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1007/s00412-008-0194-0</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ping</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Multicenter study of genetic abnormalities associated with severe oligospermia and non-obstructive azoospermia</article-title>. <source>J. Int. Med. Res.</source> <volume>46</volume> (<issue>1</issue>), <fpage>107</fpage>&#x2013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1177/0300060517718771</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>A homozygous frameshift variant in SYCP2 caused meiotic arrest and non-obstructive azoospermia</article-title>. <source>Clin. Genet.</source> <volume>104</volume> (<issue>5</issue>), <fpage>577</fpage>&#x2013;<lpage>581</lpage>. <pub-id pub-id-type="doi">10.1111/cge.14392</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>De La Fuente</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Leu</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Baumann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>McLaughlin</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Mouse SYCP2 is required for synaptonemal complex assembly and chromosomal synapsis during male meiosis</article-title>. <source>J. Cell Biol.</source> <volume>173</volume> (<issue>4</issue>), <fpage>497</fpage>&#x2013;<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200603063</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Next-generation sequencing-based molecular diagnosis of 82 retinitis pigmentosa probands from Northern Ireland</article-title>. <source>Hum. Genet.</source> <volume>134</volume> (<issue>2</issue>), <fpage>217</fpage>&#x2013;<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-014-1512-7</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>Z. M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression</article-title>. <source>J. Biomed. Sci.</source> <volume>11</volume> (<issue>3</issue>), <fpage>278</fpage>&#x2013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1007/BF02254432</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>